A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands

Status:
Completed

Trial end date:
2017-01-16

Target enrollment:

Participant gender:

The purpose of this study is to describe the efficacy and safety of bosutinib in patients with chronic myeloid leukaemia used in a real world setting

Pfizer

pH Associates